Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

L-ficolin binding and lectin pathway activation by acetylated low-density lipoprotein.

Faro J, Chen Y, Jhaveri P, Oza P, Spear GT, Lint TF, Gewurz H.

Clin Exp Immunol. 2008 Feb;151(2):275-83. Epub 2007 Nov 20.

2.

Interaction of human immunodeficiency virus (HIV) glycans with lectins of the human immune system.

Ji X, Chen Y, Faro J, Gewurz H, Bremer J, Spear GT.

Curr Protein Pept Sci. 2006 Aug;7(4):317-24. Review.

PMID:
16918446
3.
4.

Mannose binding lectin (MBL) and HIV.

Ji X, Gewurz H, Spear GT.

Mol Immunol. 2005 Feb;42(2):145-52. Review.

PMID:
15488604
5.

Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.

Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT.

J Gen Virol. 2000 Apr;81(Pt 4):949-55.

PMID:
10725420
6.

Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Suankratay C, Mold C, Zhang Y, Lint TF, Gewurz H.

Clin Exp Immunol. 1999 Sep;117(3):442-8.

7.

Enhancement of lectin pathway haemolysis by immunoglobulins.

Suankratay C, Zhang Y, Jones D, Lint TF, Gewurz H.

Clin Exp Immunol. 1999 Sep;117(3):435-41.

8.

Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.

Zhang Y, Suankratay C, Zhang X, Jones DR, Lint TF, Gewurz H.

Immunology. 1999 Aug;97(4):686-92.

9.

Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis.

Zhang Y, Suankratay C, Zhang XH, Lint TF, Gewurz H.

Immunopharmacology. 1999 May;42(1-3):81-90. Review.

PMID:
10408369
10.

Regulation of complement activation by C-reactive protein.

Mold C, Gewurz H, Du Clos TW.

Immunopharmacology. 1999 May;42(1-3):23-30. Review.

PMID:
10408362
11.
12.

Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.

Suankratay C, Zhang XH, Zhang Y, Lint TF, Gewurz H.

J Immunol. 1998 Mar 15;160(6):3006-13.

13.

Structure and function of the pentraxins.

Gewurz H, Zhang XH, Lint TF.

Curr Opin Immunol. 1995 Feb;7(1):54-64. Review.

PMID:
7772283
14.

Nonimmune activation of the classical complement pathway.

Gewurz H, Ying SC, Jiang H, Lint TF.

Behring Inst Mitt. 1993 Dec;(93):138-47. Review. No abstract available.

PMID:
8172561
16.

DNA binds and activates complement via residues 14-26 of the human C1q A chain.

Jiang H, Cooper B, Robey FA, Gewurz H.

J Biol Chem. 1992 Dec 15;267(35):25597-601.

17.

Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species.

Ying SC, Marchalonis JJ, Gewurz AT, Siegel JN, Jiang H, Gewurz BE, Gewurz H.

Immunology. 1992 Jun;76(2):324-30.

18.

A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.

Kinoshita CM, Gewurz AT, Siegel JN, Ying SC, Hugli TE, Coe JE, Gupta RK, Huckman R, Gewurz H.

Protein Sci. 1992 Jun;1(6):700-9.

20.

Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides.

Ying SC, Shephard E, de Beer FC, Siegel JN, Harris D, Gewurz BE, Fridkin M, Gewurz H.

Mol Immunol. 1992 May;29(5):677-87.

PMID:
1374844
22.

Preferential binding and aggregation of rabbit C-reactive protein with arginine-rich proteins.

Dougherty TJ, Gewurz H, Siegel JN.

Mol Immunol. 1991 Oct;28(10):1113-20.

PMID:
1922103
23.
24.

Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells.

Spear GT, Jiang HX, Sullivan BL, Gewurz H, Landay AL, Lint TF.

AIDS Res Hum Retroviruses. 1991 Jul;7(7):579-85.

PMID:
1768460
26.

Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein.

Kinoshita CM, Ying SC, Hugli TE, Siegel JN, Potempa LA, Jiang H, Houghten RA, Gewurz H.

Biochemistry. 1989 Dec 12;28(25):9840-8.

PMID:
2692716
27.
28.
29.

C-reactive protein in aging Lobund Wistar rats.

Siegel JN, Gewurz H.

Prog Clin Biol Res. 1989;287:127-32. No abstract available.

PMID:
2922422
30.

Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes.

Samberg NL, Bray RA, Gewurz H, Landay AL, Potempa LA.

Cell Immunol. 1988 Oct 1;116(1):86-98.

PMID:
2458846
31.

Evidence that serum amyloid P component binds to mannose-terminated sequences of polysaccharides and glycoproteins.

Kubak BM, Potempa LA, Anderson B, Mahklouf S, Venegas M, Gewurz H, Gewurz AT.

Mol Immunol. 1988 Sep;25(9):851-8.

PMID:
3211159
32.

Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.

Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H.

Inflammation. 1988 Aug;12(4):391-405.

PMID:
2459061
33.

Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle.

Rees RF, Gewurz H, Siegel JN, Coon J, Potempa LA.

Clin Immunol Immunopathol. 1988 Jul;48(1):95-107.

PMID:
2454772
34.
35.

Identification of multiple forms of the P component of amyloid isolated from human serum.

Kubak BM, Gewurz H, Potempa LA.

Int Arch Allergy Appl Immunol. 1988;87(2):194-203.

PMID:
3192306
36.

Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit.

Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H.

Mol Immunol. 1987 May;24(5):531-41.

PMID:
2443837
37.

Enhancement of human peripheral blood monocyte respiratory burst activity by aggregated C-reactive protein.

Zeller JM, Landay AL, Lint TF, Gewurz H.

J Leukoc Biol. 1986 Dec;40(6):769-83.

PMID:
3465838
38.
39.

Cleaved forms of C-reactive protein are associated with platelet inhibition.

Fiedel BA, Gewurz H.

J Immunol. 1986 Apr 1;136(7):2551-5.

PMID:
2419439
40.

Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.

Berman S, Gewurz H, Mold C.

J Immunol. 1986 Feb 15;136(4):1354-9.

PMID:
3944459
41.

Component deficiencies. 9. The ninth component.

Lint TF, Gewurz H.

Prog Allergy. 1986;39:307-10. No abstract available.

PMID:
3562471
42.

Component deficiencies. 7. The seventh component.

Zeitz HJ, Lint TF, Gewurz A, Gewurz H.

Prog Allergy. 1986;39:289-94. No abstract available.

PMID:
3562469
43.

The effects of C-reactive protein on human cell-mediated cytotoxicity.

Vetter ML, Gewurz H, Baum LL.

J Leukoc Biol. 1986 Jan;39(1):13-25.

PMID:
3455709
45.
46.
47.

Inhibition of antibody responses to phosphocholine by C-reactive protein.

Nakayama S, Du Clos TW, Gewurz H, Mold C.

J Immunol. 1984 Mar;132(3):1336-40.

PMID:
6363539
48.

Inhibition of neutrophil activation by alpha1-acid glycoprotein.

Costello MJ, Gewurz H, Siegel JN.

Clin Exp Immunol. 1984 Feb;55(2):465-72.

49.

Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.

Marder RJ, Potempa LA, Jones JV, Toriumi D, Schmid FR, Gewurz H.

Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:25-34.

PMID:
6375256
50.

C-reactive protein antigenicity on the surface of human lymphocytes.

James K, Baum L, Adamowski C, Gewurz H.

J Immunol. 1983 Dec;131(6):2930-4.

PMID:
6358357

Supplemental Content

Loading ...
Support Center